The Cohesive Metastasis Phenotype in Human Prostate Cancer

William L. Harryman, James P. Hinton, Cynthia P. Rubenstein, Parminder - Singh, Raymond B Nagle, Sarah J. Parker, Beatrice S. Knudsen, Anne E Cress

Research output: Contribution to journalReview article

13 Citations (Scopus)

Abstract

A critical barrier for the successful prevention and treatment of recurrent prostate cancer is detection and eradication of metastatic and therapy-resistant disease. Despite the fall in diagnoses and mortality, the reported incidence of metastatic disease has increased 72% since 2004. Prostate cancer arises in cohesive groups as intraepithelial neoplasia, migrates through muscle and leaves the gland via perineural invasion for hematogenous dissemination. Current technological advances have shown cohesive-clusters of tumor (also known as microemboli) within the circulation. Circulating tumor cell (CTC) profiles are indicative of disseminated prostate cancer, and disseminated tumor cells (DTC) are found in cohesive-clusters, a phenotypic characteristic of both radiation- and drug-resistant tumors. Recent reports in cell biology and informatics, coupled with mass spectrometry, indicate that the integrin adhesome network provides an explanation for the biophysical ability of cohesive-clusters of tumor cells to invade thorough muscle and nerve microenvironments while maintaining adhesion-dependent therapeutic resistance. Targeting cohesive-clusters takes advantage of the known ability of extracellular matrix (ECM) adhesion to promote tumor cell survival and represents an approach that has the potential to avoid the progression to drug- and radiotherapy-resistance. In the following review we will examine the evidence for development and dissemination of cohesive-clusters in metastatic prostate cancer.

Original languageEnglish (US)
Pages (from-to)221-231
Number of pages11
JournalBiochimica et Biophysica Acta - Reviews on Cancer
Volume1866
Issue number2
DOIs
StatePublished - Dec 1 2016

Fingerprint

Prostatic Neoplasms
Neoplasm Metastasis
Phenotype
Neoplasms
Circulating Neoplastic Cells
Muscles
Informatics
Drug Resistance
Integrins
Extracellular Matrix
Cell Biology
Mass Spectrometry
Cell Survival
Radiotherapy
Therapeutics
Radiation
Mortality
Incidence
Pharmaceutical Preparations

Keywords

  • adhesome
  • circulating tumor cells
  • cohesive-clusters
  • integrins
  • metastasis
  • prostate cancer

ASJC Scopus subject areas

  • Oncology
  • Genetics
  • Cancer Research

Cite this

The Cohesive Metastasis Phenotype in Human Prostate Cancer. / Harryman, William L.; Hinton, James P.; Rubenstein, Cynthia P.; Singh, Parminder -; Nagle, Raymond B; Parker, Sarah J.; Knudsen, Beatrice S.; Cress, Anne E.

In: Biochimica et Biophysica Acta - Reviews on Cancer, Vol. 1866, No. 2, 01.12.2016, p. 221-231.

Research output: Contribution to journalReview article

Harryman, William L. ; Hinton, James P. ; Rubenstein, Cynthia P. ; Singh, Parminder - ; Nagle, Raymond B ; Parker, Sarah J. ; Knudsen, Beatrice S. ; Cress, Anne E. / The Cohesive Metastasis Phenotype in Human Prostate Cancer. In: Biochimica et Biophysica Acta - Reviews on Cancer. 2016 ; Vol. 1866, No. 2. pp. 221-231.
@article{dedabaac486e4c7e94dee56a9b1b6127,
title = "The Cohesive Metastasis Phenotype in Human Prostate Cancer",
abstract = "A critical barrier for the successful prevention and treatment of recurrent prostate cancer is detection and eradication of metastatic and therapy-resistant disease. Despite the fall in diagnoses and mortality, the reported incidence of metastatic disease has increased 72{\%} since 2004. Prostate cancer arises in cohesive groups as intraepithelial neoplasia, migrates through muscle and leaves the gland via perineural invasion for hematogenous dissemination. Current technological advances have shown cohesive-clusters of tumor (also known as microemboli) within the circulation. Circulating tumor cell (CTC) profiles are indicative of disseminated prostate cancer, and disseminated tumor cells (DTC) are found in cohesive-clusters, a phenotypic characteristic of both radiation- and drug-resistant tumors. Recent reports in cell biology and informatics, coupled with mass spectrometry, indicate that the integrin adhesome network provides an explanation for the biophysical ability of cohesive-clusters of tumor cells to invade thorough muscle and nerve microenvironments while maintaining adhesion-dependent therapeutic resistance. Targeting cohesive-clusters takes advantage of the known ability of extracellular matrix (ECM) adhesion to promote tumor cell survival and represents an approach that has the potential to avoid the progression to drug- and radiotherapy-resistance. In the following review we will examine the evidence for development and dissemination of cohesive-clusters in metastatic prostate cancer.",
keywords = "adhesome, circulating tumor cells, cohesive-clusters, integrins, metastasis, prostate cancer",
author = "Harryman, {William L.} and Hinton, {James P.} and Rubenstein, {Cynthia P.} and Singh, {Parminder -} and Nagle, {Raymond B} and Parker, {Sarah J.} and Knudsen, {Beatrice S.} and Cress, {Anne E}",
year = "2016",
month = "12",
day = "1",
doi = "10.1016/j.bbcan.2016.09.005",
language = "English (US)",
volume = "1866",
pages = "221--231",
journal = "Biochimica et Biophysica Acta - Reviews on Cancer",
issn = "0304-419X",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - The Cohesive Metastasis Phenotype in Human Prostate Cancer

AU - Harryman, William L.

AU - Hinton, James P.

AU - Rubenstein, Cynthia P.

AU - Singh, Parminder -

AU - Nagle, Raymond B

AU - Parker, Sarah J.

AU - Knudsen, Beatrice S.

AU - Cress, Anne E

PY - 2016/12/1

Y1 - 2016/12/1

N2 - A critical barrier for the successful prevention and treatment of recurrent prostate cancer is detection and eradication of metastatic and therapy-resistant disease. Despite the fall in diagnoses and mortality, the reported incidence of metastatic disease has increased 72% since 2004. Prostate cancer arises in cohesive groups as intraepithelial neoplasia, migrates through muscle and leaves the gland via perineural invasion for hematogenous dissemination. Current technological advances have shown cohesive-clusters of tumor (also known as microemboli) within the circulation. Circulating tumor cell (CTC) profiles are indicative of disseminated prostate cancer, and disseminated tumor cells (DTC) are found in cohesive-clusters, a phenotypic characteristic of both radiation- and drug-resistant tumors. Recent reports in cell biology and informatics, coupled with mass spectrometry, indicate that the integrin adhesome network provides an explanation for the biophysical ability of cohesive-clusters of tumor cells to invade thorough muscle and nerve microenvironments while maintaining adhesion-dependent therapeutic resistance. Targeting cohesive-clusters takes advantage of the known ability of extracellular matrix (ECM) adhesion to promote tumor cell survival and represents an approach that has the potential to avoid the progression to drug- and radiotherapy-resistance. In the following review we will examine the evidence for development and dissemination of cohesive-clusters in metastatic prostate cancer.

AB - A critical barrier for the successful prevention and treatment of recurrent prostate cancer is detection and eradication of metastatic and therapy-resistant disease. Despite the fall in diagnoses and mortality, the reported incidence of metastatic disease has increased 72% since 2004. Prostate cancer arises in cohesive groups as intraepithelial neoplasia, migrates through muscle and leaves the gland via perineural invasion for hematogenous dissemination. Current technological advances have shown cohesive-clusters of tumor (also known as microemboli) within the circulation. Circulating tumor cell (CTC) profiles are indicative of disseminated prostate cancer, and disseminated tumor cells (DTC) are found in cohesive-clusters, a phenotypic characteristic of both radiation- and drug-resistant tumors. Recent reports in cell biology and informatics, coupled with mass spectrometry, indicate that the integrin adhesome network provides an explanation for the biophysical ability of cohesive-clusters of tumor cells to invade thorough muscle and nerve microenvironments while maintaining adhesion-dependent therapeutic resistance. Targeting cohesive-clusters takes advantage of the known ability of extracellular matrix (ECM) adhesion to promote tumor cell survival and represents an approach that has the potential to avoid the progression to drug- and radiotherapy-resistance. In the following review we will examine the evidence for development and dissemination of cohesive-clusters in metastatic prostate cancer.

KW - adhesome

KW - circulating tumor cells

KW - cohesive-clusters

KW - integrins

KW - metastasis

KW - prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=84990836943&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84990836943&partnerID=8YFLogxK

U2 - 10.1016/j.bbcan.2016.09.005

DO - 10.1016/j.bbcan.2016.09.005

M3 - Review article

C2 - 27678419

AN - SCOPUS:84990836943

VL - 1866

SP - 221

EP - 231

JO - Biochimica et Biophysica Acta - Reviews on Cancer

JF - Biochimica et Biophysica Acta - Reviews on Cancer

SN - 0304-419X

IS - 2

ER -